For its fourth fiscal quarter (ending December 31), Amedisys Inc (NASDAQ: AMED) has reported a -205% decline in E.P.S. from $0.59 a year ago to $-0.62 in the current quarter. E.P.S. were $1.32 for the […]
Sarepta Therapeutics Inc (NASDAQ: SRPT) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.65 versus $0.49 for the same period a year ago — an increase of 237%. For the latest […]
OraSure Technologies Inc (NASDAQ: OSUR) stock closed at $3.06 on 2/26/25 after a major decline of -23.5%. Moreover, trading volume in this decline was exceptionally high at 518% of normal. The stock has declined -22.7% […]
Masimo Corp (NASDAQ: MASI) stock closed at $190.47 on 2/26/25 after a major increase of 12.3%. Moreover, trading volume in this advance was exceptionally high at 304% of normal. The stock has risen 5.6% during […]
HEICO Corp (NYSE: HEI) has reported E.P.S. of $1.21 for its first fiscal quarter (ending January 31) versus $0.83 for the same period a year ago — an increase of 46%. For the latest four […]
Corcept Therapeutics Inc (NASDAQ: CORT) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.29 versus $0.30 for the same period a year ago — a decline of -3%. For the latest […]
Carriage Services Inc (NYSE: CSV) has reported E.P.S. of $0.65 for its fourth fiscal quarter (ending December 31) versus $0.78 for the same period a year ago — a decline of -17%. For the latest […]
Astec Industries Inc. (NASDAQ: ASTE) has reported E.P.S. of $0.92 for its fourth fiscal quarter (ending December 31) versus $0.65 for the same period a year ago — an increase of 42%. For the latest […]
For its fourth fiscal quarter (ending January 31), Ambarella Inc (NASDAQ: AMBA) has reported a -68% decline in E.P.S. from $-1.50 a year ago to $-0.48 in the current quarter. For the latest four quarters […]
Ambac Financial Group Inc (NYSE: AMBC) has reported E.P.S. of $0.70 for its fourth fiscal quarter (ending December 31) versus $-0.24 for the same period a year ago — a decline of -392%. For the […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research